• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Drugs

  • Print
  • Share
  • E-mail

Current Drug Shortages E - K

 

The information provided in this section is provided voluntarily by manufacturers.  FDA cannot require firms to report the reason for shortage or duration of the shortage or any other information about shortages.  FDA appreciates all information provided by manufacturers.  We post information about shortages as soon as we receive it from the manufacturers.  To report information about shortages or supply issues, manufacturers can send updates to drugshortages@fda.hhs.gov.  Healthcare professionals and patients are also encouraged to notify us of shortages at drugshortages@fda.hhs.gov.

*Food and Drug Administration Safety and Innovation Act (FDASIA) of 2012

A  B  C  D  [E– K]  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z

Edetate Calcium Disodium (Calcium Disodium Versenate) Injection (Initial Posting Date) – 10/12/2012

CompanyProductAvailability and Estimated Shortage DurationRelated InformationShortage Reason
(per New Legislation-FDASIA)*
Date Updated
Medicis Pharmaceutical Corporation:
1-800-900-6389
 
500 mg ampoules   (NDC 99207-240-10)Product available under limited distribution.
Medicis is currently in the process of securing a new manufacturer.
Dear Healthcare Professional Letter (PDF - 86KB) regarding Expiry Extension for Lot 0503.

Other
 

 

Epinephrine Injection (Initial Posting Date) – 4/27/2012

CompanyProductAvailability and Estimated Shortage DurationRelated InformationShortage Reason
(per New Legislation-FDASIA)*
Date Updated
Hospira, Inc.
Customer Service:
1-877-946-7747
1:10,000; 10 mL Abboject-1 ½ “ needle(NDC 0409-4921-34)Next delivery October Estimated recovery 2Q 2013

Please check with your wholesaler for available inventory.

Shortage per Manufacturer:
Manufacturing delays

Other

Revised 10/12/2012
1:10,000; 10 mL Abboject-3 ½ “ needle (NDC 0409-4901-18)Next delivery November Estimated recovery November
Amphastar Pharmaceuticals, Inc./IMS
Customer Service:
1-800-423-4136

1:10,000, 10mL Luer-Jet Prefilled Syringe

 

NDC 76329-3316-1

(old NDC 0548-3316-00)
Amphastar will regularly release products.

Amphastar is experiencing a product shortage due to an increase in product demand caused by market supply issues.

Shortage by Manufacturer:
Increased Demand

Demand increase for the drugReverified 9/24/2012

 

Epinephrine 1mg/mL (Preservative Free) (Initial posting-6/21/12)

CompanyProductAvailability and Estimated Shortage DurationRelated InformationShortage Reason
(per New Legislation-FDASIA)*
Date Updated
Hospira, Inc.
Customer Service:
1-877-946-7747
1 mg/mL, 1 mL ampule, preservative-free (contains sulfite), package of 25 (NDC 00409-7241-01)AvailableShortage per Manufacturer:
Available
Other

Reverified 10/12/2012

JHP Pharma
1-877-547-4547
1 mg/mL, 1 mL vial, preservative-free (contains sulfite), package of 25 (NDC 42023-122-25)Available  Revised 10/23/2012
American Regent/Luitpold
1-800-645-1706

30 mL vial, package of 5 (NDC 00517-1130-05)

UnavailableAmerican Regent is currently not releasing Epinephrine Injection. OtherReverified 10/17/2012 
1 mg/mL, 1 mL ampule, (sulfite-free)
package of 25 (NDC 00517-1071-25)

 

Erythromycin Lactobionate Injection (Initial posting-6/12/12)

CompanyProductAvailability and Estimated Shortage DurationRelated InformationShortage Reason
(per New Legislation-FDASIA)*
Date Updated
Hospira Inc. Customer Service:
1-877-946-7747
500 mg/vial;
(NDC 0409-6482-01)
Next delivery October Estimated recovery October

Please check with your wholesaler for available inventory.

Shortage per Manufacturer:
Higher than anticipated market demand

Demand increase for the drug.Revised 10/12/2012

 

Esomeprazole (Nexium) For Delayed-Release Oral Suspension (Initial Posting Date) - 4/10/2012

CompanyProductAvailability and Estimated Shortage DurationRelated InformationShortage Reason
(per New Legislation-FDASIA)*
Date Updated
AstraZeneca
1-800-236-9933

 
20 mg packets, unit: dose packages of 30 (NDC 0186-4020-01)
 

Limited availability through September

Order management will remain in effect through September.

Shortage per Manufacturer:
Manufacturing delays

OtherRevised 9/4/2012

 

Ethiodol (ETHIODIZED OIL) ampules

CompanyProductAvailability and Estimated Shortage DurationRelated InformationShortage Reason
(per New Legislation-FDASIA)*
Date Updated
Guerbet LLC
Customer Service
(1-877-729-6679)
 Guerbet has acquired the Ethiodol NDA from Nycomed US Inc. effective May 7, 2010 and is working with FDA to resume manufacturing of Ethiodol in the near future to ensure continued availability for the US patients.

During this interim period, Guerbet, in conjunction with the FDA, is initiating a temporary importation of LIPIODOL ULTRA-FLUIDE, ethyl esters of iodized fatty acids of poppy seed oil, to the United States market.

See Dear Healthcare Professional Letter (PDF - 483KB) for additional information.
(Letter updated 3/20/2012)

Shortage per Manufacturer:
Product has been discontinued by Nycomed US Inc. 

Discontinuation of the manufacture of the drug.Revised 3/16/2012

 

Etomidate Injection (Initial Posting Date) - 2/9/2012

CompanyProductAvailability and Estimated Shortage DurationRelated InformationShortage Reason
(per New Legislation-FDASIA)*
Date Updated

Sagent Pharmaceuticals

1-866-625-1618

2 mg/mL 10 mL vial (NDC 25021-0674-10)

Backordered with no restock date available

 Delay in shipping of the drug. Demand incrase for the drug.Reverified 10/222012

2 mg/mL 20 mL vial (NDC 25021-0674-20)

American Regent/Luitpold
1-800-645-1706
2 mg/mL vial
10 mL vial (NDC 00517-0780-10)
Unavailable

 

Please check with your wholesaler for available inventory.

 

Shortage per manufacturer:

American Regent is currently not releasing the 20 mL vial size of Etomidate Injection.

 

OtherRevised 10/17/2012
20 mL vial (NDC 00517-0781-10)Unavailable
 
Hospira Inc.
Customer Service
1-877-946-7747
2 mg/mL; 10 mL vial (NDC 0409-6695-01)Next delivery November Estimated recovery: 1Q 2013

Please check with your wholesaler for available inventory. 

 

Shortage per Manufacturer:
Manufacturing Delay

 

Other

Revised 10/12/2012
2 mg/mL; 20 mL vial (NDC 0409-6695-02)Next delivery December
Estimated recovery: January
2 mg/mL; 20 mL Abboject syringe (NDC 0409-8060-29)Next delivery December  Estimated recovery: January
2 mg/mL; 20 mL amp (NDC 0409-8061-01)Next delivery and estimated recovery November
2 mg/mL; 10 mL amp (NDC 0409-8062-01)Next delivery and estimated recovery December
Bedford Customer Service:
1-800-562-4797
2 mg/mL injection
10 mL vial
(NDC 55390-0762-10)
Etomidate injection is on back order with no estimated date of availability.Shortage per Manufacturer:
Manufacturing Delay
 
Discontinuation of the manufacture of the drug. 
20 mL
(NDC 55390-0763-20)
Pfizer
Customer Service:
Pfizer Injectables
1-800-533-4535
20 mg/10ml injection (NDC 0069-0006-01)Pfizer has limited supply of etomidate injection, 20 mg/10ml injection (NDC 0069-0006-01) and 40mg/20ml injection (NDC 0069-0006-03).

Shortage per Manufacturer:
Available
 

Other

Reverified 5/21/2012

 

40 mg/20ml injection (NDC 0069-0006-03)

Mylan  Institutional 1-888-258-4199

2mg/mL, 20ml, 10s (NDC 67457-183-20)

Next shipment November 2012

On back order 

Demand increase for the drug. Reverified 10/12/2012

 

Fentanyl Citrate Injection

CompanyProductAvailability and Estimated Shortage DurationRelated InformationShortage Reason
(per New Legislation-FDASIA)*
Date Updated
Hospira, Inc.
Customer Service:
1-877-946-7747
0.05 mg/mL; 2 mL Carpuject
(0409-1276-32)
Next delivery October Estimated recovery 4Q 2012

Carpuject orders (NDC 0409-1276-32) must be ordered through the wholesaler; check with your wholesaler regarding product allocation. It is recommended that the user institute fentanyl sparing strategies.

Shortage per Manufacturer:
Manufacturing delay


 

Other

Revised 10/12/2012

0.05 mg/mL; 2 mL amp
(0409-9093-32)
Next delivery October Estimated recovery 1Q 2013
0.05 mg/mL; 5 mL amp
(0409-9093-35)
Available
0.05 mg/mL; 20 mL amp
(0409-9093-38)
Available
0.05 mg/mL; 2 mL vial
(0409-9094-22)
Available
0.05 mg/mL; 5 mL vial
(0409-9094-25)
Next delivery October Estimated recovery 1Q 2013
0.05 mg/mL; 10 mL vial
(0409-9094-28)
Available
0.05 mg/mL; 20 mL vial
(0409-9094-31)
Next anticipated delivery October Estimated recovery 4Q 2013
0.05 mg/mL; 50 mL vial
(0409-9094-61)
Next anticipated delivery October Estimated recovery December
West-Ward Pharmaceuticals
Customer Service:
1-800-631-2174
(Formerly a Baxter Product)

50 mcg/mL

2 mL ampul
(NDC 0641-6024-10)

West-Ward has limited quantities available for all Fentanyl presentations.


Additional lots of all presentation are scheduled for manufacturing with anticipated released and available in the October - November 2012 timeframe.

 

 

West-Ward has continued to accelerate production on all codes.  Product will be made available as it is released.

Shortage per Manufacturer:
Increase in product demand due to market supply issues.
 

 

Demand increase for the drug.

Revised

10/4/2012

50 mcg/mL

5 mL ampul

(NDC 0641-6025-10)

50 mcg/mL

20 mL ampul

(NDC 0641-6026-05)

50 mcg/mL

2 mL vial

(NDC 0641-6027-25)

50 mcg/mL

5 mL vial

(NDC 0641-6028-25)

50 mcg/mL

20 mL vial

(NDC 0641-6029-25)

50 mcg/mL

 50 mL vial

(NDC 0641-6030-01)

Akorn Pharmaceuticals
1-800-932-5676
2 mL ampule (NDC 17478-0030-02)Readily available

 

 Other

Reverified 9/25/2012

2 mL ampule; 25 pack (NDC 17478-0030-25)

5 mL ample (NDC 17478-0030-05)
20 mL ample (NDC 17478-0030-20)

 

Fluticasone Propionate and Salmeterol (Advair HFA) Inhalation Aerosol New! (Initial Posting Date)- 10/17/2012

CompanyProductAvailability and Estimated Shortage DurationRelated InformationShortage Reason
(per New Legislation-FDASIA)*
Date Updated
GlaxoSmithKline
Customer Service:
1-888-825-5249
 

ADVAIR HFA 45/21mcg

 

(NDC# 0173-0715-20 &


0173-0715-22)
 

Out-of-Stock

Resupply expected
1Q 2013
 

All other strengths remain available.  

Shortage per Manufacturer: 
Manufacturing Delays
 

 

 

Foscarnet Sodium Injection

CompanyProductAvailability and Estimated Shortage DurationRelated InformationShortage Reason
(per New Legislation-FDASIA)*
Date Updated
Hospira, Inc.
Customer Service
1-877-946-7747
24 mg/mL; 250 mL bottle
(NDC 0409-3863-02)

Hospira has discontinued Foscarnet Sodium and now sells and distributes Clinigen’s Foscavir. See Clinigen posting below.

Effective July, 2012, Hospira sells and distributes Clinigen’s Foscavir, which is now FDA approved and available in the US.

Shortage per Manufacturer:
Hospira has discontinued Foscarnet Sodium and now sells and distributes Clinigen’s Foscavir.
 

Discontinuation of the manufacture of the drug.Reverified 10/12/2012
24 mg/mL; 500 mL bottle
(NDC 0409-3863-05)
Clinigen Healthcare

24 mg/mL; 250 mL bottle
(NDC 76310-024-25)

Effective July 11, 2012 Foscavir is available in the US.

Clinigen’s distributor is Hospira Inc.  To order product, please contact Hospira, requesting list no.  #1182-02.

Shortage per Manufacturer:
Clinigen’s Foscavir is now FDA approved and available. No further supply issues are anticipated.
 

OtherRevised 7/13/2012

 

Fosphenytoin Sodium Injection (Initial posting 3/30/12)

CompanyProductAvailability and Estimated Shortage DurationRelated InformationShortage Reason
(per New Legislation-FDASIA)*
Date Updated
Hospira, Inc.
Customer Service
1-877-946-7747
75 mg/mL; 2 mL vial (NDC 0409-4857-02)Production of both presentations is temporarily suspended.Shortage per Manufacturer:
Temporarily suspended production.
 
Discontinuation of the manufacture of the drug.Reverified 10/12/2012
75 mg/mL; 50 mL vial (NDC 0409-4857-10
APP
Customer Service
1-888-386-1300
NDC # 63323-403-02 (100 mg PE/2 mL, 2 mL vial)Next delivery expected late October 2012

All presentations currently back-ordered.  Check wholesalers for available inventory.

Shortage per Manufacturer:
Increase in Demand
 

Demand increase for the drug.Revised 10/18/2012
NDC # 63323-403-10 (500 mg PE/10 mL, 10 mL vial)Check wholesaler inventory

West-Ward Pharmaceuticals
Customer Service:
1-800-631-2174 (Formerly a Baxter Product) 

 

50 mg PE/mL
(PE = phenytoin sodium equivalents)

2 mL vial (NDC 0143-9788-25)Both presentations on backorder.
At this time, West-Ward does not have a projected availability date.
Shortage per Manufacturer:
Manufacturing delays
 
Demand increase for the drug.Revised 5/9/2012
10 mL vial (NDC 0143-9782-10)

 

Fospropofol disodium (Lusedra) Injection (Initial posting-6/18/12)

CompanyProductAvailability and Estimated Shortage DurationRelated InformationShortage Reason
(per New Legislation-FDASIA)*
Date Updated
Eisai Inc
Customer Service number- 1-888-422-4743 
1050 mg/30 mL (35 mg/mL), 30 mL vial (NDC 62856-350-08)Product is no longer available.

Shortage per Manufacturer:
Suspension of manufacturing/Market withdrawal requested
 

OtherReverified 10/9/2012 

 

Furosemide Injection (Initial posting-6/20/12)

CompanyProductAvailability and Estimated Shortage DurationRelated InformationShortage Reason
(per New Legislation-FDASIA)*
Date Updated
Hospira Inc. Customer Service:
1-877-946-7747
10 mg/mL; 4 mL Ansyr Syringe
(NDC 0409-9631-04)
Next delivery December Estimated recovery: 2Q 2013

Please check with your wholesaler for available inventory. 

 

Shortage per Manufacturer:
Manufacturing Delay

Other

Revised 10/12/2012
10 mg/mL; 2mL vial
(NDC 0409-6102-02
Next delivery October/Estimated recovery 1Q 2013
10 mg/mL; 4mL vial
(NDC 0409-6102-04)
Next delivery October/Estimated recovery 2Q 2013
10 mg/mL;10mL vial
(NDC 0409-6102-10)
Next delivery October Estimated recovery 2Q 2013
APP
1-888-386-1300
20 mg/2 mL, SDV (NDC 63323-028-002)Next delivery expected for November 2012

All presentations currently back-ordered. Check wholesalers for available inventory.

Shortage per Manufacturer:
Increased demand.
 

Demand increase for the drug.Revised 10/19/2012 
40 mg/4 mL, SDV (NDC 63323-028-004)Next delivery anticipated November
100 mg/10 mL, SDV (NDC 63323-028-010) Check wholesalers for inventory
American Regent/ Luitpold
1-800-645-1706
10 mg/mL 2 mL vial (NDC 00517-5702-25)UnavailableAmerican Regent is currently not releasing Furosemide Injection, USP. Reverified 10/17/2012 
10 mg/mL 4 mL vial (NDC 00517-5704-25)Unavailable
10 mg/mL 10 mL vial (NDC 00517-5710-25)Unavailable

 

Ganite (gallium nitrate injection) (Initial Posting - 4/4/2012)

CompanyProductAvailability and Estimated Shortage DurationRelated InformationShortage Reason
(per New Legislation-FDASIA)*
Date Updated
Genta Incorporated
1-888-TO-GENTA)
 No estimated date of availability.Business decisionDiscontinuation of the manufacture of the drug.4/4/2012

 

Helidac (bismuth subsalicylate/tetracycline hydrochloride/metronidazole) Therapy (Initial Posting - 3/8/2012)

CompanyProductAvailability and Estimated Shortage DurationRelated InformationShortage Reason
(per New Legislation-FDASIA)*
Date Updated
Prometheus Laboratories Inc.
1-888-423-5227 option 3
HELIDAC (bismuth subsalicylate/tetracycline hydrochloride/metronidazole) Therapy (NDC 65483-495-14)Prometheus has limited product available and cannot estimate a release date for new batches.Shortage per Manufacturer:
Material Shortage (Tetracycline HCl capsules)
 
Shortage of an active ingredient.4/4/2012

 

Heparin Sodium Premixes (Initial Posting - 7/5/2012)

 

CompanyProductAvailability and Estimated Shortage DurationRelated InformationShortage Reason
(per New Legislation-FDASIA)*
Date Updated

Hospira Inc. Customer Service:
1-877-946-7747

Heparin sodium 50 U/mL in 0.45% sodium chloride; 250 mL container
(NDC 0409-7651-62)

Next delivery and estimated recovery 2Q 2013

Please check with your wholesaler for available inventory.

Shortage per Manufacturer:
Manufacturing delay
 

Other

Reverified 10/12/2012

Heparin sodium 50 U/mL in .045% sodium chloride; 500 mL container
(NDC 0409-7651-03)

Next delivery and estimated recovery 2Q 2013

Heparin sodium 100 U/mL in 0.45% sodium chloride; 250 mL container (NDC 0409-7650-62)

Next delivery and estimated recovery 2Q 2013

Heparin sodium 100 U/mL in 5% dextrose; 250 mL container
(NDC 0409-7793-62)

Next delivery and estimated recovery 2Q 2013

Heparin sodium 50 U/mL in 5% dextrose; 250 mL container
(NDC 0409-7794-62)

Next delivery and estimated recovery 2Q 2013

Heparin sodium 40 U/mL in 5% dextrose; 500 mL container
(NDC 0409-7760-03)

Next delivery 2Q 2013/Estimated Recovery 3Q 2013

Heparin sodium 50 U/mL in 5% dextrose; 500 mL container
(NDC 0409-7761-03)

Next delivery and estimated recovery 3Q 2013

 

 

 

Hydromorphone Hydrochloride Injection (Initial Posting-3/7/12)

 

CompanyProductAvailability and Estimated Shortage DurationRelated InformationShortage Reason
(per New Legislation-FDASIA)*
Date Updated
Hospira, Inc.
Customer Service:
1-877-946-7747
1 mg/mL; 1 mL amp (NDC 0409-2552-01)Next delivery October/Estimated recovery 1Q 2013

Please check with your wholesaler for available inventory.

 

Demand increase for the drug

Revised 10/12/2012

1 mg/mL; 1 mL iSecure (NDC 0409-1283-10)Next delivery October Estimated recovery 2Q 2013
1 mg/mL; 1 mL Carpuject (NDC 0409-1283-31)Next delivery October/Estimated recovery December
2 mg/mL; 1 mL vial (NDC 0409-3365-01)Available
Product 2 mg/mL; 1 mL amp (NDC 0409-3356-01)Next delivery October Estimated recovery December
4mg/mL; 1mL Carpuject  (NDC 0409-1304-31)Next delivery October Estimated recovery December
2 mg/mL; 1 mL iSecure (NDC 0409-1312-10)Next delivery October Estimated recovery 2Q 2013
2mg/mL; 1mL Carpuject (NDC 0409-1312-30)Available
10mg/mL; 1mL Vial (NDC 0409-2634-01)Available
10 mg/mL; 5 mL vial (NDC 0409-2634-05)Available
10 mg/mL; 50 mL vial (NDC 0409-2634-50)Available
Teva Pharmaceuticals
1-800-545-8800
10 mg/mL, 1 mL vials (NDC 00703-0110-03)Teva has all presentations available.Shortage per Manufacturer:
Increased Demand
 
Demand increase for the drug.

Reverified 10/8/2012

10 mg/mL, 5 mL vials (NDC 00703-0113-03)
10 mg/mL, 50 mL vials (NDC 00703-0118-01)
West-Ward Pharmaceuticals
Customer Service:
1-888-229-0001
1 mL vial, 2 mg/mL
(NDC 0641-0121-25)

 

West-Ward has limited quantities available for both the 1 mL and 20 mL vial presentations.

West-Ward has increased production and is anticipating having additional lots of both presentations available in July - August 2012.

Product will be made available as it is released

Shortage per Manufacturer:
Increase in product demand due to market supply issues
 

Demand increase for the drug.Revised  7/9/2012
20 mL vial, 2 mg/mL
(NDC 0641-2341-41)

Akorn Pharmaceuticals
1-800-932-5676


 


 

10 mg/mL, 1 mL ampules (NDC 17478-0540-01)Readily available  Other

 

Revised 9/25/2012

10 mg/mL, 5 mL ampules (NDC 17478-0540-05)Readily available
10 mg/mL, 50 mL vials (NDC 17478-0540-50)

Readily available

 


 

Purdue Pharma, L.P.

Customer Service

800.877.5666

Dilaudid injection: 1 mg/mL, 1 mL ampules, package of 10 (NDC 59011-0441-10)Available  

Revised 10/17/2012

Dilaudid injection: 2 mg/mL, 1 mL ampules, package of 10 (NDC 59011-0442-10)Available
Dilaudid injection: 2 mg/mL, 1 mL ampules, package of 25 (NDC 59011-0442-25)Available
Dilaudid injection: 4 mg/mL, 1 mL ampules, package of 10 (NDC 59011-0444-10)Available
Dilaudid-HP injection
250 mg vial, powder for injection (NDC 59011-0446-25)
Available

Dilaudid-HP injection

10 mg/mL, 1 mL ampules (NDC 59011-0445-01)

Available

Dilaudid-HP injection

10 mg/mL, 5 mL ampules (NDC 59011-0445-05)

Available
Dilaudid-HP injection
10 mg/mL, 50 mL vials (NDC 59011-0445-50
Available

 

 

 

Intravenous Fat Emulsion

CompanyProductAvailability and Estimated Shortage DurationRelated InformationShortage Reason
(per New Legislation-FDASIA)*
Date Updated
Hospira Inc. Customer Service:
1-877-946-7747
10%; 250 mL (NDC 0409-9790-02)Hospira continues to investigate manufacturing process improvements.Shortage per Manufacturer:
Quality improvement activities
 
Requirements related to complying with good manufacturing practices

Reverified 10/12/2012

10%; 500 mL (NDC 0409-9790-03)
20%; 250 mL (NDC 0409-9791-02)
20%; 500 mL (NDC 0409-9791-03)
30%; 500 mL (NDC 0409-6892-03)
Baxter (Intralipid Emulsion)
Customer Service:
(1-888-229-0001)
Intralipid 20% Emulsion, 100 mL (NDC 00338-0519-48) 20%Available

Available

 

OtherReverified 9/24/2012
Intralipid 20% Emulsion, 250 mL (NDC 00338-0519-02)
Intralipid 20% Emulsion, 500 mL (NDC 00338-0519-03)
Intralipid 20% Emulsion, 1000 mL (NDC 00338-0519-04)
Intralipid 30% Emulsion, 500 mL (NDC 00338-0520-03)

 

Isoniazid Tablets   

 

CompanyProductAvailability and Estimated Shortage DurationRelated InformationShortage Reason
(per New Legislation-FDASIA)*
Date Updated
Teva Customer Service:
(888)838-2872
300 mg, 30 count (NDC 00555-0071-01)
Available. Inventory will remain low until end of year.

 

Delay in shipping of the drug.

Revised
10/18/2012
300 mg, 100 count (NDC 00555-0071-02)
Inventory will remain low until end of year.
 
300 mg, 1000 count (NDC 00555-0071-05)
Inventory will remain low until end of year.
 
100 mg, 100 count (NDC 00555-0066-02)
Available. Teva supply adequate to meet demand.
 
100 mg, 1000 count (NDC 00555-0066-05)
Available. Teva supply adequate to meet demand.
 
Sandoz Customer Service:
1-609-627-8500
300 mg, 30s (NDC 00185-4350-30)
Estimate available late-Dec 2012
Temporarily unavailable.  Sandoz is targeting product availability for late December. 
Shortage of an active ingredient.
Reverified 10/1/2012
300 mg, 100s (NDC 00185-4350-01)
Estimate available late-Dec 2012
300 mg, 1000s (NDC 00185-4350-10)
Estimate available late-Dec 2012
100 mg – 30s (NDC 00185-4351-30)
Product currently available.
100 mg, 100s (NDC 00185-4351-01)
100 mg, 1000s (NDC 00185-4351-10)
VersaPharm Service:
1-800-548-0700
300 mg, 30s (NDC 61748-0013-30)
 
Information pending
 Other
 
300 mg, 100s (NDC 61748-0013-01)
300 mg, 1000s (NDC 61748-0013-10)
100mg, 100s (NDC 61748-0016-01)

 

 

Ketorolac Injection

CompanyProductAvailability and Estimated Shortage DurationRelated InformationShortage Reason
(per New Legislation-FDASIA)*
Date Updated

Bedford Customer Service
1-800-562-4797 

15 mg/mL 1 mL vial, 10 count (NDC 55390-0480-01)

Bedford has all presentations of ketorolac injection on back order and the company cannot estimate a release date

Shortage per Manufacturer:
Manufacturing delays
 
Discontinuation of the manufacture of the drug. 
30 mg/mL 1 mL vial, 10 count (NDC 55390-0481-01)
30 mg/mL 10 mL vial, 10 count (NDC 55390-0481-10)
American Regent/Luitpold
1-800-645-1706
15 mg/mL 1 mL vial, 25 count (NDC 00517-0601-25)UnavailableAmerican Regent/Luitpold is not manufacturing Ketorolac Tromethamine Injection, USPDiscontinuation of the manufacture of the drug.

Reverified 10/17/2012

30 mg/mL 1 mL vial, 25 count (NDC 00517-0801-25)
30 mg/mL 2 mL vial for intramuscular use, 25 count (NDC 00517-0902-25)
Wockhardt
Customer Service:
1-800-346-6854

30 mg/mL 1 mL vial, 10 count (NDC 64679-0758-04)

Wockhardt is presently  experiencing intermittent releases throughout the month  Demand increase for the drug.

Revised 10/12/2012

30 mg/mL 1 mL vial, 25 count (NDC 64679-0758-01)Wockhardt is presently  experiencing intermittent releases throughout the month Demand increase for the drug.
30 mg/mL 2 mL vial, 10 count (NDC 64679-0758-06)Wochkhardt has existing inventories and no backorder presently.AvailableDemand increase for the drug.
30 mg/mL 2 mL vial, 25 count (NDC 64679-0758-02)Wockhardt is presently  experiencing intermittent releases throughout the month Demand increase for the drug.
15 mg/mL 1 mL vial, 10 count (NDC 64679-0757-02)Wockhardt is presently  experiencing intermittent releases throughout the month Demand increase for the drug.
15 mg/mL 1 mL vial, 25 count (NDC 64679-0757-01)Wockhardt is presently  experiencing intermittent releases throughout the month Demand increase for the drug.

APP
1-888-386-1300   

15 mg/mL 1 mL vial, 25 count (NDC 63323-0161-01)APP has all presentations of ketorolac injection on back order and the company cannot estimate a release date.

Shortage per Manufacturer:
Raw material supply
 

Shortage of an active ingredient.Reverified 10/4/2012
30 mg/mL 1 mL vial, 25 count (NDC 63323-0162-01)
30 mg/mL 2 mL vial for intramuscular injection, 25 count (NDC 63323-0162-02)

Hospira, Inc.
Customer Service
1-877-946-7747

15 mg/mL; 1 mL vial
(NDC 0409-3793-01)

Next delivery November Estimated recovery 2Q 2013

15 mg/mL; 1 mL Carpuject (NDC 0409-2288-31) and 30 mg/mL; 2 mL Carpuject
(NDC 0409-2287-61)  suspended production until 2013 due to manufacturing line prioritization.

Demand increase for the drug.

Revised 10/12/2012

15 mg/mL; 1 mL Carpuject
(NDC 0409-2288-31)
Suspended production
30 mg/mL; 1mL vial
(NDC 0409-3795-01)
Next delivery October Estimated recovery: 3Q 2013
30 mg/mL; 1 mL Carpuject
(NDC 0409-2287-31)
Available
30 mg/mL; 2 mL Carpuject
(NDC 0409-2287-61)
Suspended production
60 mg/mL; 2 ml vial
(NDC 0409-3796-01)
Next delivery October Estimated recovery 2Q 2013

back to top of page

Current Drug Shortages Index

-
-